Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing

NCT03984721 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT03984721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03984721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Amyloidosis Typing Using Mass Spectrometry-based Proteomics: a New Accurate Tool for Difficult Typing
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Completed
Start date
July 25, 2019
Completion date
September 8, 2021
Enrollment
27 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis